Electromed, Inc. Q4 2026 Earnings Recap

Electromed’s shares dropped 21.1% following a notable hospital revenue decline of 29% and cautious commentary around the slower, unpredictable hospital channel. Despite growth in home care and distributor channels, the market reacted negatively to the deceleration and the still uncertain hospital sales outlook.

Key Takeaways

• Total net revenue reached a record $19.4 million, up 12% year-over-year, driven by a 15% increase in the core home care channel and modest 2% growth in distribution.
• Hospital revenue fell 29%, reflecting longer sales cycles and inherent unpredictability, which pressured overall growth expectations.
• Operating income grew 26% year-over-year to $3.8 million, with earnings per share reaching $0.39.
• Sales force expanded by 6 reps, preparing for planned territory expansion in fiscal 2027.
• Payer coverage expanded to 87% of U.S. covered lives, including 40 new contracts adding over 6 million covered lives, supporting long-term market access.